← Back to headlines
Abcellera Biologics Shares Reach 52-Week Peak Following Market Rally
The biotechnology firm's stock climbed to $12.15, marking its highest valuation in over a year amid renewed investor interest in the sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
